Rhenman & Partners Asset Management AB Buys Shares of 260,000 Oscar Health, Inc. $OSCR

Rhenman & Partners Asset Management AB bought a new stake in shares of Oscar Health, Inc. (NYSE:OSCR) in the 4th quarter, Holdings Channel reports. The firm bought 260,000 shares of the company’s stock, valued at approximately $3,736,000.

Several other large investors have also modified their holdings of OSCR. Orion Porfolio Solutions LLC grew its stake in Oscar Health by 6.3% in the 4th quarter. Orion Porfolio Solutions LLC now owns 28,130 shares of the company’s stock worth $404,000 after acquiring an additional 1,671 shares in the last quarter. Cibc World Markets Corp bought a new position in Oscar Health in the 4th quarter worth about $188,000. Lane Generational LLC boosted its holdings in shares of Oscar Health by 1.2% in the fourth quarter. Lane Generational LLC now owns 220,419 shares of the company’s stock valued at $3,167,000 after purchasing an additional 2,710 shares during the period. Renaissance Technologies LLC purchased a new stake in shares of Oscar Health in the fourth quarter valued at approximately $3,536,000. Finally, Counterpoint Mutual Funds LLC purchased a new stake in shares of Oscar Health in the fourth quarter valued at approximately $506,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Down 2.1%

Shares of NYSE OSCR opened at $28.29 on Friday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.11 and a current ratio of 1.11. The firm has a market capitalization of $8.53 billion, a price-to-earnings ratio of -47.95, a PEG ratio of 2.02 and a beta of 2.37. The stock has a 50 day moving average price of $20.05 and a 200 day moving average price of $16.55. Oscar Health, Inc. has a 52-week low of $10.69 and a 52-week high of $29.42.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.96. The firm had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.90 billion. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.Oscar Health’s quarterly revenue was up 52.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.92 earnings per share. Sell-side analysts expect that Oscar Health, Inc. will post 0.47 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts recently issued reports on OSCR shares. Zacks Research lowered Oscar Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 5th. Barclays upgraded Oscar Health from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $30.00 to $35.00 in a report on Wednesday. Robert W. Baird boosted their price target on Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Jefferies Financial Group upgraded Oscar Health from an “underperform” rating to a “hold” rating and boosted their price target for the company from $10.00 to $16.00 in a report on Monday, April 20th. Finally, Wall Street Zen lowered Oscar Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 6th. Three equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $20.78.

Insider Activity at Oscar Health

In other Oscar Health news, Director Mario Schlosser sold 34,120 shares of the company’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $748,592.80. Following the completion of the sale, the director owned 480,866 shares in the company, valued at $10,550,200.04. This represents a 6.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Adam Mcananey sold 9,859 shares of the company’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $216,306.46. Following the sale, the insider owned 218,096 shares of the company’s stock, valued at approximately $4,785,026.24. This represents a 4.32% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 189,660 shares of company stock valued at $4,283,140 over the last 90 days. Insiders own 24.39% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.